Amiodarone-induced Hyperthyroidism during Massive Weight Loss Following Gastric Bypass

作者: Olivier Bourron , Cécile Ciangura , Jean-Luc Bouillot , Laurent Massias , Christine Poitou

DOI: 10.1007/S11695-008-9415-0

关键词:

摘要: Gastric bypass is increasingly used in morbidly obese patients to achieve significant reduction of body weight and fat mass concurrent improvement co-morbidities. We report the case a 53-year-old male patient (141 kg, BMI 50 kg/m2), successfully treated by amiodarone for supraventricular arrythmia, who underwent Roux-en-Y gastric (RYGBP). 6 months after surgery, he had lost 45% his preoperative (44.8% loss was lean mass) developed amiodarone-induced subclinical hyperthyroidism. hypothesize following sequence events: RYGBP, therefore loss, decrease distribution volume inducing iodine overload hyperthyroidism, reinforcing particularly mass. This emphasizes importance careful monitoring composition changes RYGBP. In this situation, checking thyroid status recommended, especially when there history disease or potentially toxic medication.

参考文章(14)
I. Giachetti, H. Dupin, J. Abraham, Recommended dietary intakes for the French population. Technique et Documentation, Lavoisier. ,(1992)
Fausto Bogazzi, Luigi Bartalena, Maurizio Gasperi, Lewis E. Braverman, Enio Martino, The various effects of amiodarone on thyroid function. Thyroid. ,vol. 11, pp. 511- 519 ,(2001) , 10.1089/105072501300176471
Bruce A. Lynch, James P. Dolan, Michael Mann, Thyrotoxicosis after gastric bypass surgery prompting operative re-exploration. Obesity Surgery. ,vol. 15, pp. 883- 885 ,(2005) , 10.1381/0960892054222803
Albrecht Pfeiffer, Nicole Vidon, Martine Bovet, Monique Rongier, Jean-Jacques Bernier, Intestinal absorption of amiodarone in man The Journal of Clinical Pharmacology. ,vol. 30, pp. 615- 620 ,(1990) , 10.1002/J.1552-4604.1990.TB01864.X
Roberto Latini, Gianni Tognoni, Robert E. Kates, Clinical pharmacokinetics of amiodarone. Clinical Pharmacokinectics. ,vol. 9, pp. 136- 156 ,(1984) , 10.2165/00003088-198409020-00002
João Régis I. Carneiro, Raul G. A. Macedo, Vinícius G. Da Silveira, Thyrotoxicosis after Gastric Bypass Obesity Surgery. ,vol. 14, pp. 699- 701 ,(2004) , 10.1381/096089204323093525
Muriel Coupaye, Jean-Luc Bouillot, Christine Poitou, Yves Schutz, Arnaud Basdevant, Jean-Michel Oppert, Is lean body mass decreased after obesity treatment by adjustable gastric banding Obesity Surgery. ,vol. 17, pp. 427- 433 ,(2007) , 10.1007/S11695-007-9072-8
Arnaud Basdevant, Michel Paita, Marie-Héléne Rodde-Dunet, Michel Marty, Françoise Noguès, Karem Slim, Jean-Marc Chevallier, A nationwide survey on bariatric surgery in France: two years prospective follow-up. Obesity Surgery. ,vol. 17, pp. 39- 44 ,(2007) , 10.1007/S11695-007-9004-7
John Gill, Rennie C. Heel, Andrew Fitton, Amiodarone Drugs. ,vol. 43, pp. 69- 110 ,(1992) , 10.2165/00003495-199243010-00007
C M Newman, A Price, D W Davies, T A Gray, A P Weetman, Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy Heart. ,vol. 79, pp. 121- 127 ,(1998) , 10.1136/HRT.79.2.121